Data sharing in Canada through the COGR:

Similar documents
TABLE D-1 POST-M.D. TRAINEES EXITING QUEBEC TRAINING PROGRAMS IN JULY, 2014 AT THE COMPLETION OF POST-M.D. TRAINING

POST-M.D. TRAINEES EXITING ALBERTA TRAINING PROGRAMS IN JULY, 2015 AT THE COMPLETION OF POST-M.D

Geographic Location, Field of Post-M.D. Training

NATIONAL HOUSEHOLD SURVEY BRIEF FERTILITY RATES OF OTTAWA'S JEWISH COMMUNITY

Geographic Location, Field of Post-M.D. Training

NATIONAL HOUSEHOLD SURVEY BRIEF FERTILITY RATES OF TORONTO'S JEWISH COMMUNITY

ANTIMICROBIAL RESISTANT ORGANISMS (ARO) SURVEILLANCE

TABLE D-1 POST-M.D. TRAINEES EXITING ONTARIO TRAINING PROGRAMS IN JULY, 2013 AT THE COMPLETION OF POST-M.D. TRAINING

Quarter Performance Report

Quarter Performance Report

Impaired driving statistics

NATIONAL SYNERGISTIC CORE RESOURCES. Kidney REsearch Scientist Core Education and National Training program (KRESCENT)

CIHR grant opportunity for using CANUE data August 17 th am 10am pacific 12noon 1pm eastern

Scientific Advisory Committee Medical Devices Used in Cardiovascular Systems. Membership List and Biographies

The Technical Aspects of Pathogen Testing in Canada. Nancy Angus Canadian Blood Services Director, Testing

Together we ve achieved many successes. THE CH.I.L.D. FOUNDATION

Respiratory Virus Detections in Canada Respiratory Virus Report, Week 10 - ending March 9, 2019

Antifungal Susceptibility of Aspergillus Isolates from the Respiratory Tract of Patients in Canadian Hospitals: Results of the CANWARD 2016 Study.

Poison Control Centres

GERIATRIC MEDICINE PROFILE

Prevalence of cannabis-impaired driving and crash risk

Trends in the Study of Aboriginal Health Risks in Canada

Estimating organ donor potential: a comparable tool to track performance, identify gaps and help save lives

DERMATOLOGY PROFILE GENERAL INFORMATION

Health Canada Endorsed Important Safety Information on Infanrix Hexa

2012 Year In Review In Review. Number of Patients on WaitList as of Number Of Transplants Year. Number Of Patients

Technology to support a Community of Practice Promoting Healthy Built Environment Policies

Physiotherapists in Canada, 2011 National and Jurisdictional Highlights

2014 Year End Review

National, volunteer-based charity focused on finding the cures for Crohn s Crohn's and Colitis Canada

Estimating the volume of Contraband Sales of Tobacco in Canada

Report from the National Diabetes Surveillance System:

2017 Year End Review

OneMatch : A Closer Look. Gail Morris Principal Case Manager April 2017

People Living with HIV/AIDS in Canada: A Determinants of Health Perspective Preliminary Findings of the Population-Specific HIV/AIDS Status Report

Poisoning and Poison Control Centres across Canada

Pathways to Eating in Children and Adolescents with Obesity

Public Health Guidelines for Sedentary Behaviour

Canadian Association of Gastroenterology Clinical Practice Guidelines: The use of infliximab in Crohn s disease

Echocardiography. The Tenth Annual CANADIAN ECHO WEEKEND. Educational Symposium of the. Canadian Society of Echocardiography

2017 International Meeting on Non-Alcoholic Fatty Liver Disease (NAFLD)

West Nile Virus and Other Mosquito-borne Diseases National Surveillance Report English Edition September 18 to September 24, 2016 (Week 38)

ENDOCRINOLOGY/METABOLISM PROFILE

SUMMARY OF CURRICULUM VITAE LUIS SOUHAMI, MD

OTOLARYNGOLOGY PROFILE

WCWEA. Membership. May 9-11, 2018

Update on Royal College Areas of Focused Competence (Diploma) Programs. Application Sponsor: National Body / Specialty Society

Characterization and proposed nomenclature of epidemic strains of MRSA in Canada

Rick Hansen Spinal Cord Injury Registry: special report

Organ Donation and Transplantation in Canada. System Progress Report 2017 Update

West Nile Virus and Other Mosquito-borne Diseases National Surveillance Report English Edition September 11 to September 17, 2016 (Week 37)

The epidemiology of invasive diseases caused by Haemophilus influenzae type a (Hia), a report from IMPACT

1. To provide an update of the diagnosis, pathophysiology, outcome, screening and management of pregnancies complicated by IUGR.

Drug Safety Pharmacosurveillance: The Future is Now & Spelled G-e-n-o-m-I-c-s

CAPhO Oncology Fundamentals Day Saturday, October 1, 2016

OxyContin in the 90 days prior to it being discontinued.

PROVINCIAL LEAD AND LHIN LEADER BIOS

# Claims with disp.fee > 0. Average cost submitted by Rx**

Estimated Number and Percentage of Alcohol and Impairment- Related Crash Fatalities and Injuries, by Jurisdiction, Age and Population: Canada, 2009

West Nile virus and Other Mosquito-borne Diseases National Surveillance Report August 6 to August 12, 2017 (Week 32)

Update on Royal College Areas of Focused Competence (Diploma) Programs. Application Sponsor: National Body / Specialty Society

West Nile virus and Other Mosquito-borne Diseases National Surveillance Report July 30 to August 5, 2017 (Week 31)

Renal Transplant Past Present and Future David Landsberg

Canadian Pediatric Anesthesia Research Network HIGHLIGHTS: Launch Meeting, November 5, 2009

NATIONAL SURVEILLANCE OF OSTEOARTHRITIS AND RHEUMTOID ARTHRITIS IN CANADA

CRS 2014 Chapter Report Chicago Canada Chapter

The Terry Fox Pan-Canadian Enhanced Pancreatic Cancer Profiling for Individualized Care (EPPIC) Project 19 Sep :00am-5:30pm

Health Interventions in Ambulatory Cancer Care Centres

The Incursion and Expansion of West Nile Virus into Canada

Variant Classification: ACMG recommendations. Andreas Laner MGZ München

Canadian National Vaccine Safety (CANVAS) Network: Active Safety Surveillance for Influenza Vaccine, 2013 and 2014

Canadian Stroke Best Practice Recommendations STROKE PREVENTION WRITING GROUP 2017:

Sarah Jennings, BSc, BScPhm, RPh, PharmD Knowledge Mobilization Officer Thursday May 28, 2015 Canadian Pharmacists Conference

Supply, Distribution and Migration of Canadian Physicians, 2010

The effect of immune conditions on pesticide use and the risk of non- Hodgkin lymphoma. Manisha Pahwa, OCRC CARWH Conference June 2, 2012

CANADA 150 ATLANTIC TO PACIFIC CELEBRATION. An All Canadian World Record Celebration

Cannabinoid Medical Clinic

West Nile virus and Other Mosquito borne Diseases National Surveillance Report English Edition

Important Information Regarding Platelets Apheresis, LR Product Update

ADHD and Education Survey March The Centre for ADHD Awareness, Canada

Marlene Bagatto. The University of Western Ontario, London, Canada. Sound Foundations 2010, Chicago, USA

Aussi disponible en français sous le titre : Le Diabète au Canada : Rapport du Système national de surveillance du diabète, 2009

TABLE OF CONTENTS WELCOME 3 THE GOC COMMUNITIES OF PRACTICE 7 PROGRAM 9 HOTEL FLOOR PLAN 20 TRAVEL AND ACCOMMODATIONS 21 PARKING AND DIRECTIONS 22

Recent trends in medical cannabis use in Canada

FRAILTY, DEMENTIA AND DISASTERS: WHAT HEALTH CARE PROVIDERS NEED TO KNOW

Implementing Rapid Response Teams (RRT) National Call September 13, 2007

Ellen MacDonald on behalf of

VOLUNTEERING WITH CYSTIC FIBROSIS CANADA

Services and Fee Schedule Effective Dec 8, 2017

Pharmacists in Canada A national survey of Canadians on their perceptions and attitudes towards pharmacists in Canada.

Organ Donation and Transplantation in Canada

ORTHOPEDIC SURGERY PROFILE

Services and Fee Schedule Effective May 14, 2018

INFLUENZA IN CANADA SEASON

EDUCATION PROGRAMS. Educational Sessions for Long Term Care + Retirement

December 3 to 9, 2017 (Week 49)

YP National Forum. ACEC Summit 2013 Lake Louise, Alberta. ACEC Canada Young Professional Network NATIONAL FORUM

Economic Burden of Musculoskeletal Diseases in Canada

Hand and Wrist Fracture Management Course

Transcription:

Data sharing in Canada through the COGR: a unified clinical genome database as a community resource for standardizing and sharing genetic interpretations Dr. Matthew Lebo, Kathleen-Rose Zakoor, Dr. Jordan Lerner-Ellis and the Canadian Open Genetics Repository Working Group

Overview Grant funded by Genome Canada Collaborative effort for the collection, sharing and analysis of variants reported by medical diagnostic laboratories across Canada Collaborate with other global initiatives including ClinVar, BRCA Challenge, Human Variome Project 2

Objectives To create Canada s unified, open-access, clinical-grade genetic database using a commonly shared platform Standardize variant assessment procedures Data extraction and variant classification consensus building Data Access and Disseminate results to a large public repository 3

Workflow Overview 4

COGR storage and sharing The COGR Consensus Database holds variants with consensus classifications across labs Sharing is optional at the discretion of the lab and only enabled upon request 5

23 GeneInsight Instances Created Organization Upload Status Sharing Status Alberta Children's Hospital, Calgary AB Uploaded Sharing Atlantic Cancer Research Institute, Moncton NB Pending - British Columbia Cancer Agency, Vancouver BC Uploaded Sharing Children s & Women s Health Centre of BC, Vancouver BC Uploading - Children's Hospital of Eastern Ontario, Ottawa ON Uploaded Sharing* Credit Valley Hospital, Trillium Health Centre, Mississauga ON Uploaded Sharing Dept of Medical Genetics, University of Alberta, Edmonton AB Uploading - Hamilton Health Sciences, McMaster University, Hamilton ON Uploaded - Impact Genetics Inc., Bowmanville ON Pending - Izaak Walton Killam Health Centre, Dalhousie University, Halifax NS Uploading - Jewish General Hospital, Montréal QC Uploading Kingston General Hospital, Queen s University, Kingston ON Uploaded Sharing McGill University Health Complex, Montréal QC Uploaded - Memorial Health University Medical Center, St. John s NL Pending - Mount Sinai Hospital, University of Toronto, Toronto ON Uploaded Sharing* North York General Hospital, Toronto ON Uploaded Sharing Ontario Institute of Cancer Research (OICR), Toronto ON Uploaded Sharing Regional Health Authority, University of Manitoba, Winnipeg MB Uploading Sharing Sainte-Justine Hospital, University of Montreal, Montréal QC Uploading - SickKids Hospital and McLaughlin Centre, Toronto ON Uploaded Sharing University Hospital, Western University, London ON Pending - Women's College Hospital, University of Toronto, Toronto ON Uploaded Sharing* *Also sharing with VariantWire 6

COGR Variant Numbers COGR Comparison 2014/2015 14000 12000 10000 8000 >17,000 variants 1,266 genes 66 diseases 6000 4000 2000 0 Variants Copy Number Variants 2014 3802 3339 2015 12607 4659 7

The COGR Recent Initiative 2016 marks the COGR s 4 th year Focus to make data holdings both extremely accurate and readily accessible Focus on creating and dispersing lab specific discrepancy reports Build consensus clinical interpretations on variants identified in Canadian diagnostic laboratories and academic medical centers Initial project looked at BRCA1/2 8

9

COGR - BRCA Participating Institutions COGR-BRCA Participant COGR Participant A. Alberta Children s Hospital (Calgary, AB) B. Atlantic Cancer Research Institute (Moncton, NB) C. British Columbia Cancer Agency (Vancouver BC) D. Children s & Women s Health Centre of BC (Vancouver BC) E. Children s Hospital of Eastern Ontario (Ottawa ON) F. Credit Valley Hospital, Trillium Health Centre (Mississauga ON) G. Dept of Medical Genetics, University of Alberta (Edmonton, AB) H. Hamilton Health Sciences, McMaster University (Hamilton, ON) I. Impact Genetics Inc. (Bowmanville, ON) J. Izaak Walton Killam Health Centre (Halifax, NS) K. Kingston General Hospital, Queen s University (Kingston, ON) L. McGill University Health Complex (Montréal, QC) M. Memorial Health University Medical Center (St. John s, NL) N. Mount Sinai Hospital, University of Toronto (Toronto, ON) O. North York General Hospital (Toronto ON) P. Ontario Institute of Cancer Research (OICR) (Toronto, ON) Q. Regional Health Authority, University of Manitoba (Winnipeg, MB) R. Sainte-Justine Hospital, University of Montreal (Montréal, QC) S. SickKids Hospital and McLaughlin Centre (Toronto, ON) T. University Hospital, Western University (London, ON) U. Women s College Hospital, University of Toronto (Toronto, ON) 10 V. Jewish General Hospital, Montreal (Montréal, QC)

Discrepancy Report Results Overview 1. Overall discrepancy report results 2. Total changes in classifications and reasoning 3. Changes in discrepant variant classifications 4. Methods for reassessment 11 participating labs across 4 provinces ON, BC, AB, MB Received total of 5,554 BRCA1/2 variants 3014 unique variants 1,148 seen in >2 labs 110 to 1072 variants per lab (505 on average) 11

Submission Data - Before Issuing Discrepancy Reports After data submission 1,148 unique variants were identified in more than one lab 550 (48%) of variants had concordant classifications 350 (30%) were discordant 248 (22%) were unclassified by all labs *According to 5-tier classification system 12

Tiered Discrepancy Systems 5-tiered - Initially implemented 3-tiered - Recommended by participants 2-tieried - Clinical management 13

After Review of Discrepancy Report Results 42% of discordant variants changed classifications 28% did not change classifications 30% were not reassessed Initial Interpretations Final Interpretations # Variants % # Variants % Overall Change Benign 526 37% 637 45% 111 (8%) Likely Benign 271 19% 321 23% 50 (4%) VUS 342 24% 211 15% 127 (9%) Likely Pathogenic 60 4% 64 5% 4 (>1%) Pathogenic 136 10% 170 12% 34 (2%) Unclassified 75 5% 9 1% 72 (5%) Total 1410 1410 398 (28%) 14

Number of Unique Variants Final Discrepancy Results 1000 900 800 770 887 700 600 622 5-Tier 3-Tier 500 2-Tier 400 300 278 200 100 0 Concordant 130 13 Discrepant 15

After Review of Discrepancy Report Results Only 18% of the discrepant variants reached a consensus for 5-tier system But most labs did not review minor discrepancies Benign vs Likely Benign Pathogenic vs Likely Pathogenic In total, for 5-tier system: 69% (622/900) of all unique & classified variants were concordant In total, for 3-tier system (LB/B, VUS, LP/P) 86% (770/900) of all unique & classified variants were concordant 16

Reasoning For Reclassification 9 out of 11 labs specified reasoning for some variants 64% of reassessed variants provided reclassification reasoning: 8% Typographical error 13% Based on new evidence provided 42% 37% Revised classification criteria Other (Please specify) 17

Methods Used for Reassessment Most labs did not review variants through the COGR network 8 out of 11 labs specified their reassessment methods 34% of variants had specified reassessment methods: 45% 6% 6% 43% We used our own methodology or tools to reassess We used the COGR variant assessment tool (VAT) We used the ACMG reclassification tool provided Other 18

Summary Successful exercise with positive feedback within the COGR community Limited resources provide challenges for labs to do this without guidance and help Continuing initiatives: Release quarterly discrepancy reports Provide consensus variant interpretations through public database Further collaboration with other international data-sharing efforts including ClinVar, the HVP and the GA4GH 19

opengenetics.ca This work was funded by the Government of Canada through Genome Canada and the Ontario Genomics Institute (OGI-070) 20